FIELD: biotechnology.
SUBSTANCE: described are variants of the Fc region, having high activity and/or selectivity of binding with FcγRIIb, compared to FcγRIIa (R-type), compared to polypeptide binding activity and/or selectivity, containing Fc-region, in which amino acid modification(s) was(were) not introduced; polypeptide comprising said version of Fc region. Also presented is a corresponding pharmaceutical composition for treating or preventing inflammatory diseases or oncological diseases.
EFFECT: versions of the FcγRIIb-specific Fc region are disclosed.
15 cl, 37 dwg, 27 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING VARIANTS OF FCYRIIB-SPECIFIC FC-REGION | 2013 |
|
RU2820161C1 |
| ANTIGEN-BINDING MOLECULE TO ACCELERATE ANTIGEN DISAPPEARANCE THROUGH FcγRIIB | 2013 |
|
RU2812226C1 |
| ANTIGEN-BINDING MOLECULE TO ACCELERATE ANTIGEN DISAPPEARANCE THROUGH FCΓRIIB | 2013 |
|
RU2736349C2 |
| Fc-REGION OPTION | 2014 |
|
RU2757124C2 |
| POLYPEPTIDE VARIANT THAT HAS PRESERVED OR DECREASED BINDING ACTIVITY TO FcγRIIa, PHARMACEUTICAL COMPOSITION CONTAINING IT AND THEIR APPLICATION | 2012 |
|
RU2749357C2 |
| ANTIGEN-BINDING MOLECULE FOR ACCELERATING ANTIGEN LOSS | 2012 |
|
RU2772771C1 |
| CARRIER CONTAINING A DRUG INTO A CELL FOR FORMING AN IMMUNE COMPLEX | 2012 |
|
RU2739792C1 |
| HYBRID PROTEINS OF HUMAN PROTEIN FRAGMENTS TO CREATE ORDERED MULTIMERIZED COMPOSITIONS OF IMMUNOGLOBULIN FC REGIONS WITH ENHANCED BINDING WITH A COMPLEMENT SYSTEM | 2016 |
|
RU2737378C2 |
| ANTIGEN-BINDING MOLECULE INDUCING AN IMMUNE RESPONSE TO A TARGET ANTIGEN | 2012 |
|
RU2722829C2 |
| MUTANT VARIANTS OF Fc IgG1 DEVOID OF EFFECTOR FUNCTIONS | 2018 |
|
RU2764559C2 |
